University of Wisconsin–Madison

A Seamless Phase IIa/IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of MK-7622 as an Adjuncitve Therapy to Donepezil for Symptomatic Treatment in Subjects with Alzheimer’s Disease

September 2014 to October 2017

This project led by: Sanjay Asthana MD